What should you know about double immunohistochemistry?

Short answer
Double immunohistochemistry applies two targeted stains to one tissue section, helping the pathology team see whether different markers occur in the same cells or in neighbouring cells.
This answers one question. It is not a diagnosis and does not replace an assessment by a licensed doctor.
At a glance
- Sample
- Prepared tissue, often from a biopsy
- What is examined
- Two selected tissue markers on one section
- Who interprets it
- A pathologist, together with the wider clinical picture
The short answer
The result is interpreted alongside the tissue appearance, clinical information, and any other pathology tests. It is a way of adding detail to a tissue examination, not a diagnosis by itself.
What double immunohistochemistry means
Immunohistochemistry uses antibodies designed to bind to selected substances, called markers, in prepared tissue. A visible stain shows where a marker is present. In a double stain, two marker targets are assessed on the same section, often with different colours or other distinguishable signals.
Looking at both signals together can help distinguish cell types, identify cells that share a marker pattern, or clarify how an abnormal area relates to surrounding tissue. The method may be useful when a single stain does not provide enough context. A pathologist still considers whether the staining is present, where it appears, and how strongly or consistently it is seen.
The test is performed on tissue obtained during a biopsy or another procedure. It does not usually require a separate sample from you, although the laboratory may need suitable preserved tissue.
What to do after it is requested
You generally do not need to prepare for the laboratory stain itself. Keep the appointment or procedure plan provided by your care team, and tell them about medicines, allergies, or health conditions that could affect the biopsy or tissue procedure.
When the report is available, ask which markers were tested, what the combined pattern showed, and whether the finding changes the diagnosis or next step. Some results support classification of a tumour, while others help separate similar-looking conditions. The report may also say that the stain was inconclusive or that additional testing is needed.
For background on the broader laboratory method, see [Immunohistochemistry](/technology/immunohistochemistry/). If tissue was collected for testing, [Biopsy](/treatments/diagnostics-and-staging/biopsy/) explains how that procedure fits into diagnosis.
When to seek care
Double immunohistochemistry itself is a laboratory analysis, so it does not create symptoms that need urgent review. Seek prompt medical help after a biopsy or related procedure if you develop heavy bleeding, worsening pain, spreading redness, fever, or drainage from the site.
Contact the team handling your report if the expected result has not arrived or if you do not understand whether the finding is conclusive. New or worsening symptoms should be assessed on their own; a tissue stain cannot determine the cause of every symptom.
Questions for your doctor
Which two markers were examined, and what do they indicate in this tissue?
Were the markers seen in the same cells, separate cell groups, or the surrounding tissue?
Does this result confirm a diagnosis, narrow the possibilities, or point to another test?
How will the pathology finding affect treatment planning or the next appointment?
Questions people ask
Is double immunohistochemistry a separate biopsy?
Usually, it is an additional laboratory stain performed on suitable tissue already collected during a biopsy or another procedure.
Does a double stain mean that cancer has been confirmed?
No. It provides marker information that may help classify tissue, but the pathologist interprets it with the tissue pattern and other clinical and laboratory findings.
Why might more tests be requested afterward?
The tissue may need further marker testing or another method if the combined staining pattern does not answer the diagnostic question clearly.
Related
Related reading
Keep reading
Cancer care in the UAE
Hospitals & Medical Centers in Abu Dhabi
Most UAE cancer care is delivered inside hospital services rather than by standalone oncology clinics, so these are licensed hospitals & medical centers listed in Abu Dhabi. Confirm the specific cancer service exists before you travel, and know that asking for a second opinion is routine.
Ahalia Hospital Musaffah Building - Musaffah - Musaffah Industrial - Abu Dhabi - United Arab Emirates
Accepts: Daman, Thiqa, AXA, Cigna +26 more
Al Ruwais Industrial City - Abu Dhabi - United Arab Emirates
Accepts: Daman, Thiqa, AXA, Cigna +30 more
Abu Dhabi, Abu Dhabi
Accepts: Daman, Thiqa, AXA, Cigna +30 more
Second opinions are routine in cancer care and asking for one does not affect your treatment. How to arrange a second opinion in the UAE.
Ordered by verification status and how complete each clinic's public record is, then alphabetically. This is a directory listing, not a ranking — Zavis does not rate or recommend providers.
A factual listing drawn from the DHA, DOH and MOHAP licence registers. It is not a referral, an endorsement, or advice that any of these providers is right for you.
Medical disclaimer. This page is general health information, not medical advice, and it cannot diagnose you. Always consult a licensed healthcare provider about your own symptoms and treatment. In an emergency in the UAE, call 998 for an ambulance.